| 000 | 01674 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515192416.0 | ||
| 264 | 0 | _c20100416 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/ard.2009.115717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToms, Tracey E | |
| 245 | 0 | 0 |
_aStatin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cApr 2010 |
||
| 300 |
_a683-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 700 | 1 | _aPanoulas, Vasileios F | |
| 700 | 1 | _aDouglas, Karen M J | |
| 700 | 1 | _aGriffiths, Helen | |
| 700 | 1 | _aSattar, Naveed | |
| 700 | 1 | _aSmith, Jaqueline P | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 700 | 1 | _aNightingale, Peter | |
| 700 | 1 | _aMetsios, George S | |
| 700 | 1 | _aKitas, George D | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 69 _gno. 4 _gp. 683-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2009.115717 _zAvailable from publisher's website |
| 999 |
_c19244750 _d19244750 |
||